Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent disease after liver transplantation

T J Davern1, J R Lake

  • 1Department of Medicine, University of California, San Francisco 94143-0538, USA.

Seminars in Gastrointestinal Disease
|August 13, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OPTN/SRTR 2020 Annual Data Report: Liver.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2022
Same author

OPTN/SRTR 2019 Annual Data Report: Liver.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2021
Same author

The Impact of Tenofovir Disoproxil Fumarate on Reduced Bone Mineral Density and Fractures in Liver Transplant Recipients.

Transplantation proceedings·2020
Same author

OPTN/SRTR 2018 Annual Data Report: Hepatitis C.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2020
Same author

OPTN/SRTR 2018 Annual Data Report: Liver.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2020
Same author

OPTN/SRTR 2017 Annual Data Report: Liver.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2019

Liver transplant recipients often experience disease recurrence, particularly from viral hepatitis B (HBV) and C (HCV). While HBV recurrence is serious, advances now improve outcomes, but antiviral resistance is a future concern for HBV and HCV.

Area of Science:

  • Hepatology
  • Transplantation Medicine
  • Immunology

Background:

  • Liver transplantation is a life-saving procedure for end-stage liver disease.
  • Disease recurrence post-transplantation is a significant clinical challenge.
  • Recurrence rates and impacts vary widely among different liver diseases.

Purpose of the Study:

  • To review the clinical impact and management of liver disease recurrence after transplantation.
  • To discuss the specific challenges posed by viral hepatitis B (HBV) and hepatitis C (HCV) recurrence.
  • To highlight advances in preventing HBV recurrence and the unmet needs in managing recurrent HCV.

Main Methods:

  • Review of existing literature on liver disease recurrence post-transplantation.
  • Analysis of clinical outcomes associated with recurrent autoimmune and viral liver diseases.

Related Experiment Videos

  • Evaluation of current strategies for preventing and managing post-transplant hepatitis B and C.

    • Main Results:

    • Autoimmune liver disease recurrence is generally rare and controversial.
    • Hepatitis B virus (HBV) recurrence significantly worsens prognosis without prevention strategies.
    • Hepatitis C virus (HCV) recurrence has a more benign short-term prognosis but lacks effective therapies.
    • Advances in HBV prophylaxis have dramatically improved outcomes for transplant patients with chronic hepatitis B.

    Conclusions:

    • Effective prevention of HBV reinfection has transformed outcomes for liver transplant recipients with chronic hepatitis B.
    • Antiviral resistance is an emerging challenge for managing recurrent HBV.
    • Recurrent hepatitis C remains a major unmet need in liver transplantation due to the lack of effective treatments.